Empo Health Raises $7M to Launch Remote Diabetic Foot Ulcer Management System

Whats Happening:

Empo Health has secured $7 million in funding to commercialize its innovative solution for diabetic foot ulcer (DFU) management. The company's system combines an FDA-listed imaging scale with a HIPAA-compliant remote monitoring service, enabling regular at-home foot checks for early intervention by healthcare providers. This funding brings Empo's total capital raised to $15 million.

Key Moves:

• Empo Health raises $7 million for commercialization of DFU management solution

• Company launches FDA-listed Empo Footprint scale and HIPAA-compliant Remote Health Link service

• Three new members join Empo's Board of Directors following the financing

By The Numbers:

• Over 20 million Americans suffer from diabetic neuropathy

• DFUs consume up to $80 billion in US healthcare spending annually

• Empo's total capital raised to date is $15 million

Key Quotes:

• "We believe that the patients most in need of health monitoring currently have the most difficult access to it. We founded Empo to change that," said Anuj Khandelwal, Co-Founder & CEO of Empo Health.

• "Empo represents a critical change in the technology landscape," said Brian Yormak, Managing Partner of Story Ventures.

• "The Empo Footprint is designed from the ground up to be approachable and simple for the patient, taking only a few seconds for the entire interaction," said Eric Dahlseng, Co-Founder and Chief Product Officer of Empo Health.

Bottom Line:

Empo Health's $7 million funding round marks a significant step in addressing the critical issue of diabetic foot ulcers. By providing an easy-to-use, at-home monitoring solution, Empo aims to improve patient outcomes, reduce healthcare costs, and potentially prevent amputations. The company's innovative approach could transform DFU management and have a substantial impact on the lives of millions of diabetic patients.

Read Full Article